Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
The 3rd BIO International Convention 2022 is Approaching 2022-06-07 19:23
PHASE II STUDY OF PAXALISIB IN BRAIN METASTASES ADVANCES TO EXPANSION STAGE IN BREAST CANCER BRAIN METASTASES COHORT 2022-06-07 19:00
Molecular Stethoscope, Inc. announces new investment from the Alzheimer's Drug Discovery Foundation 2022-06-07 18:00
Chordia Therapeutics Announces Interim Results of the Phase 1 Clinical Trial of CLK Inhibitor CTX-712 at the 2022 ASCO Annual Meeting 2022-06-07 14:00
Chordia Therapeutics Announces Interim Results of the Phase 1 Clinical Trial of CLK Inhibitor CTX-712 at the 2022 ASCO Annual Meeting 2022-06-07 14:00
SCG Cell Therapy And A*STAR's IMCB Collaborate To Accelerate Clinical Translation of Immune Cell-based Therapy 2022-06-07 12:23
Antengene Announces HREC Approval in Australia for the Phase I Trial of the Small Molecule ATR Inhibitor ATG-018 2022-06-07 11:34
ASCO 2022 | Ascentage Pharma Releases Updated Results Demonstrating the Therapeutic Potential of Alrizomadlin (APG-115) plus Pembrolizumab in Patients with Solid Tumors who Progressed on Immunotherapies 2022-06-07 11:30
ASCO 2022 | The First Dataset of Olverembatinib (HQP1351) in Patients with GIST Demonstrates Therapeutic Potential with a Clinical Benefit Rate of 83.3% 2022-06-07 11:28
Pharmactive Enters Strategic Partnership with Nutraconnect for APAC 2022-06-07 09:00
iNtRON Completes GLP-TOX Studies of BAL200 2022-06-07 09:00
CStone presents pre-specified overall survival data of sugemalimab for first-line treatment of stage IV non-small cell lung cancer at ASCO 2022 2022-06-07 08:02
Innovent and AnHeart Jointly Present Updated Phase 2 Efficacy and Safety Data of Taletrectinib (ROS1-TKI) at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting 2022-06-07 08:00
Telix Showcasing Innovation in Theranostics at SNMMI 2022-06-07 05:00
MGI Announces Commercial Availability of DNBSEQ™ Sequencers* in the United States 2022-06-07 00:59
Menarini Group and Radius Health, Inc. present a subgroup analysis from the elacestrant pivotal phase 3 EMERALD clinical trial at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting 2022-06-06 23:07
Prenetics Announces First Quarter 2022 Financial Results After a Successful Listing on the Nasdaq under the Ticker "PRE" 2022-06-06 21:55
IND approval from the US FDA for Phase II SAR-Bombesin imaging trial in prostate cancer 2022-06-06 21:08
Insilico Medicine Raises $60 Million in Series D Financing to Advance Pipeline and Launch AI-powered Drug Discovery Robotics Laboratory 2022-06-06 21:00
Insilico Medicine Raises $60 Million in Series D Financing to Advance Pipeline and Launch AI-powered Drug Discovery Robotics Laboratory 2022-06-06 21:00
1 238 239 240 241 242 890